Midostaurin in addition to intensive chemotherapy in acute myeloid leukemia with t(8;21) and <i>KIT</i> and/or <i>FLT3</i>- ITD mutations: results of the SAL MIDOKIT trial
Bewaard in:
| Hoofdauteurs: | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Ferrata Storti Foundation
2023-02-01
|
| Reeks: | Haematologica |
| Online toegang: | https://haematologica.org/article/view/10973 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|
